IP Library Granted Patent US 6,926,885
Granted Patent B2
US 6,926,885 · App. 10/180,272 · Granted Aug 9, 2005

In-vivo diagnostic method by means of near infrared radiation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,926,885
App. No.
10/180,272
Granted
Aug 9, 2005
Kind
B2
Abstract

This invention relates to an in-vivo diagnostic method based on near infrared radiation (NIR radiation) that uses water-soluble dyes and their biomolecule adducts, each having specific photophysical and pharmaco-chemical properties, as a contrast medium for fluorescence and transillumination diagnostics in the NIR range, to new dyes and pharmaceuticals containing such dyes.

Claims (16)

1. A cyanine dye as represented by the general formula V:

wherein

Q is a fragment selected from the group consisting of

where R 30 represents a hydrogen atom, a hydroxy group, a carboxy group, an alkoxy residue containing 1 to 4 carbon atoms or a chlorine atom, b is an integer 2 or 3, R 31 represents a hydrogen atom or an alkyl residue containing 1 to 4 carbon atoms,

X and Y independently represent an —O—, —S—, —CH═CH— or —C(CH 2 R 32 )(CH 2 R 32 )— fragment each,

R 20 to R 29 , R 32 and R 33 independently represent a hydrogen atom, a hydroxy group, a carboxy-, a sulfonic acid residue or a carboxyalkyl-, alkoxycarbonyl or alkoxyoxoalkyl residue containing up to 10 C atoms or a sulfoalkyl residue containing up to 4 C atoms, or a non-selectively bonding macromolecule or a residue of the general formula VI

—(O) v —(CH 2 ) o —CO—NR 34 —(CH2) s —(NH—CO) q —R 35   (VI)

on the condition that, where X and Y are O, S, —CH═CH— or —C(CH 3 ) 2 — at least one of the residues R 20 to R 29 corresponds to a non-selectively bonding macromolecule or a compound of the general formula VI, where

o and s equal 0 or independently represent an integer between 1 and 6,

q and v independently represent 0 or 1, R 34 represents a hydrogen atom or a methyl residue, R 35 represents an alkyl residue containing 3 to 6 C atoms and comprising 2 to n−1 hydroxy groups, with n being the number of C atoms, or an alkyl residue containing 1 to 6 C atoms that carries 1 to 3 additional carboxy groups, an aryl residue containing 6 to 9 C atoms or arylalkyl residue containing 7 to 15 C atoms, or a residue of the general formula IIId or IIIe

on the condition that q is 1,

or a non-selectively bonding macromolecule,

or R 20 and R 21 , R 21 and R 22 , R 22 and R 23 , R 24 and R 25 , R 25 and R 26 , and/or R 26 and R 27 , together with the interspersed carbon atoms, form a 5- or 6-member aromatic or saturated annelled ring,

and its physiologically tolerable salts.

2. An agent for in-vivo diagnosis comprising the cyanine dye according to claim 1 together with physiologically acceptable adjuvants, substrates, and/or diluents.

3. A method of diagnosing tumours tissue comprising administering the cyanine dye claimed in claim 1 , irradiating the tumours tissue with light in the visible to near infrared range and recording fluorescent radiation produced form the cyanine dye.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2011
From: LICHA, KAI; RIEFKE, BJORN; SEMMLER, WOLFHARD; SPECK, ULRICH; HILGER, CHRISTOPH-STEPHAN
To: INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH AN DER FREIEN UNIVERSITAT BERLIN
Reel/Frame 026976/0313 →
INTELLECTUAL PROPERTY TRANSFER AGREEMENT Recorded Aug 30, 2011
From: BAYER SCHERING PHARMA AG
To: VISEN MEDICAL, INC.
Reel/Frame 026829/0625 →
MERGER Recorded Aug 30, 2011
From: INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH
To: BAYER SCHERING PHARMA AG
Reel/Frame 026892/0387 →